People with pancreatic cancer often struggle to keep their weight up. This is a serious problem because losing weight can make the disease harder to treat. A large review looked at nine studies to see if adding omega-3 fats, like EPA and DHA, could help. These fats are found in fish oil and are sometimes used to support nutrition. The review found that patients who took these supplements gained a small amount of body weight. This was a positive sign for people fighting this difficult illness. However, the review did not find that these fats helped build lean muscle or improve blood protein levels. Those are also important markers of health for cancer patients. The researchers were careful to note that the evidence has low certainty. Many of the studies were small, and the results varied a lot from one group to another. This means we cannot be sure if the weight gain was truly helpful or just happened by chance. The findings do not prove that these fats will improve overall nutrition or survival. Doctors should still discuss individual cases with their care teams before starting any new supplement. The current data is not enough to say these fats are a standard treatment for everyone.
Systematic review and meta-analysis of n-3 PUFAs for pancreatic cancer patientsOmega-3 fats show modest weight gain in pancreatic cancer patients
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Consider n-3 PUFA supplementation may modestly increase weight in pancreatic cancer patients, but evidence is low certainty.
This is a systematic review and meta-analysis of nine randomized controlled trials examining n-3 polyunsaturated fatty acid (PUFA) supplementation, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in patients with pancreatic cancer. The primary outcome was body weight, with secondary outcomes including lean body mass, body mass index, serum albumin, and serum prealbumin.
The authors synthesized findings showing a modest, statistically significant weight gain with n-3 PUFA supplementation (standardized mean difference [SMD] 1.41; 95% CI 0.36 to 2.46; p = 0.008). In contrast, the meta-analysis found no statistically significant effects on lean body mass (SMD 0.21; 95% CI -0.38 to 0.81; p = 0.48), body mass index (weighted mean difference 0.59; 95% CI -0.42 to 1.60; p = 0.25), serum albumin (SMD -0.07; 95% CI -0.81 to 0.66; p = 0.84), or serum prealbumin (SMD 0.13; 95% CI -0.18 to 0.43; p = 0.42).
The authors acknowledge key limitations, including low certainty of evidence, substantial heterogeneity among trials, and small sample sizes. Safety data were not reported in the included studies. Causality was not established, and the evidence is insufficient to support meaningful improvement in overall nutritional status.
Practice relevance is restrained; the authors conclude that recommendations should remain individualized rather than routine. The certainty of evidence was rated as low for body weight and serum albumin, moderate for lean body mass, body mass index, and serum prealbumin.
What this means for you:
Omega-3 fats may help gain a little weight, but evidence is uncertain and does not prove better nutrition. More on Cancer
Combined EPA and DHA supplementation showed no broad benefit for major adverse cardiovascular events in patients with established disease
New research shows combined fish oil supplements did not lower heart attack risk for patients with existing heart disease
This meta-analysis evaluated combined eicosapentaenoic acid and docosahexaenoic acid supplementation in patients with established cardiovasc…
A large study of over 25,000 patients found that taking moderate doses of EPA and DHA together did not significantly reduce major heart even…
Percutaneous Cervical Cordotomy reduces pain and opioid consumption in patients with severe cancer pain
Procedure Shows Relief for Severe Treatment Resistant Cancer Pain
This meta-analysis of randomized controlled trials evaluates percutaneous cervical cordotomy (PCC) for managing treatment-resistant cancer p…
A surgical procedure called percutaneous cervical cordotomy may reduce severe cancer pain and lower the amount of opioids needed by patients…
Mandala painting and music therapies improve quality of life and psychological well-being in cancer survivors
Art and music therapies improve well-being for cancer survivors
This network meta-analysis of 2,542 cancer survivors suggests that mandala painting therapy significantly improves quality of life and reduc…
New research shows that mandala painting and music therapy can help cancer survivors manage depression, fatigue, and overall quality of life…
Liquid biopsy technologies utilizing NGS and machine learning improve analytical sensitivity for early cancer detection
Liquid Biopsies Show Promise for Early Multi-Cancer Detection
This mini-review synthesizes current literature on liquid biopsy modalities including ctDNA, exosomes, and epigenetic fingerprints for multi…
New liquid biopsy technologies use machine learning and advanced testing to detect multiple types of cancer early through a simple blood sam…
View Original Abstract ↓
BACKGROUND: Patients with pancreatic cancer frequently experience malnutrition that is often unresponsive to conventional nutritional interventions.
OBJECTIVE: To evaluate the impact of n-3 polyunsaturated fatty acids (PUFAs), specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), supplementation on body weight (BW), lean body mass (LBM), body mass index (BMI), serum albumin (ALB), and serum prealbumin (PA) in this population. This systematic review was prospectively registered with PROSPERO (CRD42023402888).
METHODS: Reviewers searched PubMed, Embase, Cochrane Library, Web of Science, Scopus, and ProQuest from inception to 31 January 2026. Risk of bias was assessed using the Cochrane Risk of Bias Tool (RoB 1.0). Statistical analyses were performed using RevMan 5.4. Certainty of evidence was evaluated using GRADEpro GDT.
RESULTS: Nine randomized controlled trials (RCTs) were included and analyzed. Risk of bias was low in two studies, unclear in six, and high in one. The meta-analysis indicated that n-3 PUFAs may produce modest weight gain (SMD 1.41, 95% CI [0.36-2.46]; = 0.008; low certainty, = 94%), though clinical significance is uncertain. No statistically significant effects were observed on LBM (SMD 0.21, 95% CI [-0.38-0.81]; = 0.48; moderate certainty), BMI (WMD 0.59, 95% CI [-0.42-1.60]; = 0.25; moderate certainty), ALB (SMD -0.07, 95% CI [-0.81-0.66]; = 0.84; low certainty), or PA (SMD 0.13, 95% CI [-0.18-0.43]; = 0.42; moderate certainty).
CONCLUSION: This meta-analysis suggests that n-3 PUFAs may produce modest weight gain, but evidence is insufficient to support meaningful improvement in overall nutritional status. Due to low certainty, substantial heterogeneity, and small sample sizes, recommendations remain individualized rather than routine. Well-designed, large-scale trials are needed to clarify which patients may benefit from this intervention.
Combination of Local Treatment and Systemic Therapy Improves Outcomes in Patients with Hepatocellular Carcinoma
Combining local and systemic treatments improves survival in liver cancer
Related in Oncology
Eosinophils as dual pro-inflammatory and immunoregulatory cells in allergic rhinitis
Eosinophils May Play Dual Roles in Allergic Rhinitis Treatment
This mini review synthesizes evidence that eosinophils in allergic rhinitis have both pro-inflammatory and immunoregulatory functions, inclu…
New research into eosinophils suggests these cells have complex roles that could help doctors develop more precise treatments for allergic r…
Intravesical gemcitabine and docetaxel provide effective treatment for high-risk non-muscle-invasive bladder cancer
Sequential gemcitabine and docetaxel show promise for bladder cancer
This systematic review and meta-analysis of 883 patients evaluated the efficacy and safety of intravesical sequential gemcitabine and doceta…
A new treatment combination involving two drugs may offer an effective way to manage high-risk bladder cancer while remaining well tolerated…
8-year disease-free survival after surgery alone for clear cell adenocarcinoma of the urethra
Surgery alone yields 8-year survival in rare urethral cancer
This case report and literature review describes a 39-year-old woman with clear cell adenocarcinoma of the urethra who achieved 8-year disea…
A woman with a rare urethral cancer remained cancer-free for 8 years after surgery alone, a case report shows.
Tumor Treating Fields and pulsed electric fields modulate cell death and immune microenvironment in neoplasms
Electric fields may help fight tumors and overcome treatment resistance
This systematic review examines the mechanisms of electrical stress transduction into biochemical signals. The authors synthesize evidence t…
New research explores how electric fields can trigger cell death in tumors and help the body's immune system fight cancer more effectively.
From Other Specialties
B cell and humoral immunity pathways provide potential targets for modulating inflammation in Inflammatory Bowel Disease
B Cell Therapies Show Potential for Inflammatory Bowel Disease
This systematic review evaluates the B cell-humoral immunity regulatory axis in patients with inflammatory bowel disease (IBD). The authors …
New research highlights how targeting B cells and antibody pathways may help manage inflammation in people with inflammatory bowel disease.
Metabolic reprogramming in the tumor microenvironment drives immune evasion and immunotherapy resistance in gastric cancer
How stomach cancer tricks the immune system to survive
This narrative review explores how metabolic crosstalk and nutrient competition within the tumor microenvironment influence immune suppressi…
Stomach cancer cells starve immune cells of nutrients and flood the area with waste, helping the tumor hide from treatment.
Gut microbiota dysbiosis linked to osteoarthritis pathology in preclinical and human studies
Gut health may play a role in osteoarthritis joint pain
This narrative review synthesizes evidence linking gut microbiota dysbiosis to osteoarthritis. Human studies show OA-associated changes in m…
New research suggests that imbalances in gut bacteria could contribute to cartilage damage and inflammation in people with osteoarthritis.
Cagrilintide-semaglutide reduces HbA1c by up to 2.33% in adults with type 2 diabetes
New insulin combination shows promise for managing type 2 diabetes
This Phase 3a randomized controlled trial of 274 adults with type 2 diabetes found that adding cagrilintide-semaglutide to basal insulin sig…
A new drug combination added to daily insulin helps lower blood sugar and body weight in adults with type 2 diabetes.